Swedish Biotech Atrogi Doses First Subjects in ATR-258 Trial, Focusing on Muscle Preservation in Obesity Treatment Stockholm-based clinical-stage biotechnology company Atrogi AB has begun dosing participants in a new human …
Tag:
Clinical trials
-
-
WHO Task Force Aims to Include Pregnant and Breastfeeding Women in Clinical Trials by 2030 Pregnant and breastfeeding women have historically been underrepresented in medical research, leading to significant gaps …
-
GLP-1 Receptor Agonists and Cancer Risk: A Comprehensive Update Glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed for type 2 diabetes management, have gained significant attention for their role in weight …
-
China’s Wangli Technology Secures Funding for AI-Powered Digital Mental Health Platform Wangli Technology, a Chinese digital mental health diagnosis and therapy platform, has completed a Series B+ funding round, raising …
-
Novartis’ Remibrutinib Shows Promise as First Targeted Therapy for Chronic Inducible Urticaria Basel, Switzerland – February 24, 2026 – Novartis announced positive results from its Phase III RemIND trial evaluating …
-
AI-Powered Stethoscopes Show Promise in Cardiovascular Disease Detection, But Implementation Challenges Remain Early detection is critical for managing cardiovascular disease, a leading cause of death globally. A recent large-scale trial …
-
Disc Medicine Inc FDA acknowledged that AURORA and BEACON provided sufficient evidence that bitopertin significantly lowers PPIX and that there is a strong mechanistic and biological plausibility supporting the use …
-
Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia (UNIMORE), Modena, Italy Johanna M. C. Blom, Ciara Staunton & Luca Pani Center for Neuroscience and Neurotechnology, University of Modena …
-
As the grandfather of a girl with a rare disease, I’ve learned that for families like ours, hope often comes not as a cure, but as a clinical trial: carefully …
-
Base-Edited CAR T-Cell Therapy Shows Promise in T-Cell Acute Lymphoblastic Leukemia Recent advancements in cancer immunotherapy are offering new hope for patients battling aggressive blood cancers. A groundbreaking research highlight …